KORU Medical Systems (NASDAQ:KRMD) Rating Increased to Strong-Buy at B. Riley

KORU Medical Systems (NASDAQ:KRMD - Get Free Report) was upgraded by investment analysts at B. Riley to a "strong-buy" rating in a research note issued on Thursday,Zacks.com reports.

A number of other research analysts have also weighed in on KRMD. Canaccord Genuity Group lifted their price objective on shares of KORU Medical Systems from $3.00 to $4.00 and gave the company a "buy" rating in a research note on Thursday, November 14th. Lake Street Capital lifted their price objective on shares of KORU Medical Systems from $4.00 to $5.00 and gave the company a "buy" rating in a research note on Tuesday, January 14th. Craig Hallum lifted their price objective on shares of KORU Medical Systems from $5.00 to $6.00 and gave the company a "buy" rating in a research note on Friday, January 17th. Finally, Piper Sandler reiterated a "neutral" rating and issued a $4.50 price objective on shares of KORU Medical Systems in a research note on Friday, February 14th. One analyst has rated the stock with a hold rating, three have assigned a buy rating and one has issued a strong buy rating to the stock. According to MarketBeat, KORU Medical Systems has an average rating of "Buy" and a consensus price target of $4.70.

KORU Medical Systems Stock Performance

KORU Medical Systems stock traded up $0.02 during mid-day trading on Thursday, reaching $2.92. The company's stock had a trading volume of 247,425 shares, compared to its average volume of 136,435. KORU Medical Systems has a 12-month low of $2.05 and a 12-month high of $5.05. The company has a market capitalization of $133.84 million, a P/E ratio of -11.68 and a beta of 0.74. The company has a debt-to-equity ratio of 0.01, a quick ratio of 2.37 and a current ratio of 2.99. The firm's fifty day moving average price is $3.90 and its two-hundred day moving average price is $3.41.

Remove Ads

Institutional Trading of KORU Medical Systems

Hedge funds have recently made changes to their positions in the stock. Geode Capital Management LLC lifted its holdings in shares of KORU Medical Systems by 6.5% during the 3rd quarter. Geode Capital Management LLC now owns 462,128 shares of the company's stock worth $1,262,000 after acquiring an additional 28,323 shares during the last quarter. Y Intercept Hong Kong Ltd bought a new stake in shares of KORU Medical Systems during the 4th quarter worth $104,000. Connor Clark & Lunn Investment Management Ltd. lifted its holdings in shares of KORU Medical Systems by 77.7% during the 3rd quarter. Connor Clark & Lunn Investment Management Ltd. now owns 61,412 shares of the company's stock worth $168,000 after acquiring an additional 26,860 shares during the last quarter. Calamos Advisors LLC bought a new stake in shares of KORU Medical Systems during the 4th quarter worth $250,000. Finally, XTX Topco Ltd bought a new stake in shares of KORU Medical Systems during the 3rd quarter worth $34,000. 58.60% of the stock is owned by institutional investors.

KORU Medical Systems Company Profile

KORU Medical Systems, Inc develops and manufactures medical devices and supplies in the United States and internationally. It offers the freedom infusion systems to deliver life-saving therapies to patients with chronic illnesses, such as primary immunodeficiency diseases, chronic inflammatory demyelinating polyneuropathy, and paroxysmal nocturnal hemoglobinuria.